Photosynthesis: Oxygen overload
Bioreactors of algae are commonly used to generate biomass, a renewable source of energy. To do this, scientists exploit the algae’s ability to efficiently convert carbon dioxide into organic compounds, such as sugar, using photosynthesis. This process is known as carbon fixation and requires high levels of inorganic carbon in order to be successful. If the primary enzyme involved in this reaction – called Rubisco (short for ribulose-1,5-bisphosphate carboxylase/oxygenase) – does not receive enough carbon dioxide, it mistakenly fixes oxygen instead. This results in unfavourable by-products that inhibit photosynthesis and require lots of energy to recycle (Peterhansel et al., 2010).
To overcome this problem, algae evolved a carbon dioxide concentrating mechanism (CCM) that allows the rate of photosynthesis to remain high despite low levels of inorganic carbon (Badger and Price, 1992; Raven et al., 2017). Much of what is known about the CCM has come from studying a single cell alga known as Chlamydomonas (Mackinder et al., 2017). These studies revealed two key components that allow the CCM to increase the concentration of carbon dioxide around Rubisco enzymes: transporter proteins that pump carbon dioxide into the chloroplast, and structures called pyrenoids which sequester Rubisco enzymes. Pyrenoids are condensed proteins which are often surrounded by a starch sheath that promotes the selective entry of carbon dioxide and shields Rubisco from oxygen. However, the mechanisms and signals underlying the formation of these pyrenoids have largely remained elusive.
Past and current research has mostly focused on pyrenoids that appear when CCMs are induced by low levels of inorganic carbon (Wang et al., 2015). Now, in eLife, David M Kramer (Michigan State University) and colleagues – including Peter Neofotis (also from Michigan State) as first author – report that pyrenoids may also be induced by high levels of oxygen, in the absence of other CCM components (Neofotis et al., 2021).
The team – which included researchers from Michigan State and ExxonMobil – found that a species of alga called Chlamydomonas reinhardtii contains pyrenoids when there are extremely high levels of oxygen in the air (also known as hyperoxia) despite carbon dioxide levels also being high (Figure 1). The structure of these oxygen-induced pyrenoids is strikingly similar to those formed in response to low levels of inorganic carbon. This led Neofotis et al. to hypothesize that the signal that induces pyrenoid formation may be produced when photosynthesis takes place either under hyperoxia conditions or when there are low levels of carbon dioxide.
The signalling molecule hydrogen peroxide was considered to be the strongest candidate for the role as it is a by-product of oxygen fixation, a scenario that can occur when oxygen levels are high or when there are insufficient amounts of carbon dioxide (Figure 1). Further experiments showed that hydrogen peroxide levels and the formation of pyrenoids are highly correlated, providing strong evidence for this hypothesis.
To address the role pyrenoids play under high oxygen stress, Neofotis et al. studied and compared Chlamydomonas strains which have varying tolerance to hyperoxia. The experiments showed that the pyrenoids found in these genetic variants have different structures and sometimes fail to form a sheath. Algae that could endure high levels of oxygen and formed fully starch-sheathed pyrenoids had significant growth advantages over those that had more fragmented and poorly developed sheaths. This is consistent with the theory that pyrenoids also help to enhance photosynthesis under hyperoxia conditions, in addition to their role in the CCM.
Many questions remain to be answered to fully understand how hydrogen peroxide signalling leads to the formation of pyrenoids, regardless of whether low levels of inorganic carbon or hyperoxia are the eliciting cue. It is possible that other signals may affect the formation of pyrenoids, perhaps in response to other environmental stresses. Furthermore, how pyrenoids assemble and the specific roles of each of their different parts still remain to be explored. Nevertheless, the work of Neofotis et al. sets the scene for new, exciting avenues of research that may lead to the development of more efficient algae that can be used in bioreactors and other biotechnological applications.
The CO2 concentrating mechanism in cyanobacteria and microalgaePhysiologia Plantarum 84:606–615.https://doi.org/10.1111/j.1399-3054.1992.tb04711.x
PhotorespirationThe Arabidopsis Book 8:e0130.https://doi.org/10.1199/tab.0130
The possible evolution and future of CO2-concentrating mechanismsJournal of Experimental Botany 68:3701–3716.https://doi.org/10.1093/jxb/erx110
Article and author information
- Version of Record published: December 22, 2021 (version 1)
© 2021, Foerster
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
- Page views
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
SARS-CoV-2 emergent variants are characterized by increased viral fitness and each shows multiple mutations predominantly localized to the spike (S) protein. Here, amide hydrogen/deuterium exchange mass spectrometry has been applied to track changes in S dynamics from multiple SARS-CoV-2 variants. Our results highlight large differences across variants at two loci with impacts on S dynamics and stability. A significant enhancement in stabilization first occurred with the emergence of D614G S followed by smaller, progressive stabilization in subsequent variants. Stabilization preceded altered dynamics in the N-terminal domain, wherein Omicron BA.1 S showed the largest magnitude increases relative to other preceding variants. Changes in stabilization and dynamics resulting from S mutations detail the evolutionary trajectory of S in emerging variants. These carry major implications for SARS-CoV-2 viral fitness and offer new insights into variant-specific therapeutic development.
- Biochemistry and Chemical Biology
Ciliopathies manifest from sensory abnormalities to syndromic disorders with multi-organ pathologies, with retinal degeneration a highly penetrant phenotype. Photoreceptor cell death is a major cause of incurable blindness in retinal ciliopathies. To identify drug candidates to maintain photoreceptor survival, we performed an unbiased, high-throughput screening of over 6,000 bioactive small molecules using retinal organoids differentiated from induced pluripotent stem cells (iPSC) of rd16 mouse, which is a model of Leber congenital amaurosis (LCA) type 10 caused by mutations in the cilia-centrosomal gene CEP290. We identified five non-toxic positive hits, including the lead molecule reserpine, which maintained photoreceptor development and survival in rd16 organoids. Reserpine also improved photoreceptors in retinal organoids derived from induced pluripotent stem cells of LCA10 patients and in rd16 mouse retina in vivo. Reserpine-treated patient organoids revealed modulation of signaling pathways related to cell survival/death, metabolism, and proteostasis. Further investigation uncovered dysregulation of autophagy associated with compromised primary cilium biogenesis in patient organoids and rd16 mouse retina. Reserpine partially restored the balance between autophagy and the ubiquitin-proteasome system at least in part by increasing the cargo adaptor p62, resulting in improved primary cilium assembly. Our study identifies effective drug candidates in preclinical studies of CEP290 retinal ciliopathies through cross-species drug discovery using iPSC-derived organoids, highlights the impact of proteostasis in the pathogenesis of ciliopathies, and provides new insights for treatments of retinal neurodegeneration.